Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(33%)
Results Posted
100%(1 trials)
Terminated
1(33%)

Phase Distribution

Ph phase_2
1
33%
Ph not_applicable
1
33%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Completed1
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (33.3%)
Phase 31 (33.3%)
N/A1 (33.3%)

Trials by Status

completed133%
terminated133%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
terminatedphase_3

The Paediatric EVICEL® Neuro Study

NCT02309645
recruitingnot_applicable

Sutures Versus Polyglactin Mesh in Hiatal Hernia Repair

NCT05201508
completedphase_2

A Study to Evaluate the Safety and Effectiveness of EVICEL as an Adjunct to Sutured Dural Repair

NCT01174992

Clinical Trials (3)

Showing 3 of 3 trials
NCT02309645Phase 3

The Paediatric EVICEL® Neuro Study

Terminated
NCT05201508Not Applicable

Sutures Versus Polyglactin Mesh in Hiatal Hernia Repair

Recruiting
NCT01174992Phase 2

A Study to Evaluate the Safety and Effectiveness of EVICEL as an Adjunct to Sutured Dural Repair

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3